Revised intimation for Closure of Trading Window.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bharat Parenterals Ltd has informed the stock exchanges that its trading window for equity shares will remain closed starting Wednesday, October 01, 2025, until 48 hours after the declaration of Unaudited Financial Results (standalone and consolidated) for the quarter and half year ending September 30, 2025. During this period, all Designated Persons and their immediate relatives are prohibited from trading in the company's shares. Additionally, PANs of Designated Persons and their immediate relatives will be frozen at the CDSL depository portal in line with SEBI circulars. The date of the Board Meeting to approve the Q2/H1 FY26 results will be communicated separately.
This is a routine compliance filing ahead of upcoming quarterly results and does not signal any positive or negative event. It restricts insiders from trading until results are publicly disclosed, which is standard practice under SEBI insider trading regulations and has no direct impact on shareholders or stock price.